CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
876716-32-4 | | (5-methyl-1h-tetrazol-1-yl)(phenyl)acetic acid | | | | |
876716-43-7 | | 1-cyclopropyl-5-oxopyrrolidine-3-carboxylic acid | | | | |
876716-46-0 | | 3-cyclohexylisoxazole-5-carboxylic acid | | | | |
876716-55-1 | | (6-methyl-1h-benzoimidazol-2-ylmethoxy)-acetic acid | | | | |
876716-58-4 | | 2-(3,5-dimethyl-piperidin-1-yl)-ethylamine | | | | |
876716-61-9 | | (tetrahydro-2h-pyran-2-ylmethoxy)acetic acid | | | | |
876716-77-7 | | 1-ethyl-2,3-dihydro-1h-indole-5-carbaldehyde | | | | |
876716-89-1 | | 4-methyl-2-morpholin-4-yl-thiazole-5-carboxylic acid | | | | |
876717-12-3 | | 4-(aminomethyl)-n,n,1-trimethylpiperidin-4-amine | | | | |
876717-29-2 | | 1-[2-(2-methyl-1h-imidazol-1-yl)phenyl]methanamine | | | | |
876717-32-7 | 1-甲基-4-(乙氨基)哌啶 | 4-(ethylamino)-1-methylpiperidine | | | | |
876717-41-8 | 2-(2-甲氧基-乙基)-嘧啶-5-甲醛 | 2-(2-methoxyethyl)pyrimidine-5-carbaldehyde | | | | |
876717-44-1 | | 1-(pyrrolidin-1-ylmethyl)cyclohexanamine | | | | |
876717-50-9 | | 6-ethoxy-5-indanecarbaldehyde | | | | |
876717-51-0 | | 2-chloro-n-(7-hydroxy-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-acetamide | | | | |
876717-53-2 | | 2-(methylamino)isonicotinic acid | | | | |
876717-62-3 | | 3-isopropyl-5-methylisoxazole-4-carboxylic acid | | | | |
876717-71-4 | | n*1*-(3-methoxy-benzyl)-n*1*-methyl-ethane-1,2-diamine | | | | |
876717-86-1 | | 2-furan-2-yl-2-morpholin-4-yl-ethylamine | | | | |
876717-98-5 | | 2-(1-pyrrolidinylmethyl)-benzoic acid hcl | | | | |
876718-04-6 | 3,4,5,6-四氢-2h-[1,2']联吡啶-3-甲酸 | 3,4,5,6-tetrahydro-2h-[1,2']bipyridinyl-3-carboxylic acid | | | | |
876721-10-7 | | 1-isopropyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine | | | | |
876721-15-2 | | 4-[3-(4-methoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-butyric acid | | | | |
876728-43-7 | | (9h-fluoren-9-yl)methyl 4-(but-3-enoyl)piperazine-1-carboxylate | | | | |
87673-13-0 | | n,n-diethyl-2-((2-methyl-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)-ethanamin | | | | |
87673-14-1 | | n,n-diethyl-2-((4-methyl-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)-ethanamin | | | | |
87673-15-2 | | 2-((2-chloro-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)-n,n-diethyl-ethanamin | | | | |
87673-16-3 | | n,n-diethyl-2-((2-ethyl-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)-ethanamin | | | | |
87673-17-4 | | n,n-diethyl-2-((2-fluoro-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)-ethanamin | | | | |
87673-18-5 | | n,n-dimethyl-2-((2-ethyl-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)-ethanamin | | | | |
87673-19-6 | | ethanamine, n,n-dimethyl-2-((2-fluoro-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio) | | | | |
87673-20-9 | | ethanamine, n,n-bis(1-methylethyl)-2-((2-ethyl-6,11-dihydrodibenz(b,e)oxepin-11 | | | | |
87673-21-0 | | ethanamine, n,n-bis(1-methylethyl)-2-((2-fluoro-6,11-dihydrodibenz(b,e)oxepin-1 | | | | |
87673-22-1 | | ethanamine, n,n-dimethyl-2-((3-methyl-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio) | | | | |
87673-88-9 | 1-甲基-4,5,6,7-四氢-1h-咪唑并[4,5-c]吡啶 | 1-methyl-4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine | | | | |
87674-09-7 | | 3-fluoro-2-(trimethylsilyl)pyridine | | | | |
87674-15-5 | 1-(3-氟吡啶-4-基)乙醇 | 1-(3-fluoropyridin-4-yl)ethanol | | | | |
87674-18-8 | | 2-bromo-3-pyridinecarboxamide | C6H5BrN2O | 201.02 | | |
87674-20-2 | 2-乙酰基-3-氟吡啶 | 2-acetyl-3-fluoropyridine | | | | |
87674-21-3 | 3-氟-4-乙酰基吡啶 | 4-acetyl-3-fluoropyridine | | | | |
87674-68-8 | 二甲吩草胺 | 2-Chloro-N-(2,4-dimethyl-3-thienyl)-N-(2-methoxy-1-methylethyl)acetamide | C12H18ClNO2S | 275.79 | | |
876755-79-2 | | (R)-2-(boc-amino)-2-(4-isopropoxyphenyl)acetic acid | | | | |
87676-07-1 | | n-(2-methoxy-1-methylethyl)-2,4-dimethyl-3-thiophenamin | | | | |
87676-93-5 | | 2,4-triazole-1-ethanol, alpha-(2-fluorophenyl)-alpha-(4-fluorophenyl)-1h- (+ | | | | |
876761-75-0 | | n-boc-amino-(1,4-dioxa-spiro[4.5]dec-8-yl)-acetic acid | | | | |
87679-37-6 | | (2S-(1(r*(r*)),2-alpha,3a-alpha,7a-beta))-)amino)-1- oxopropyl) | | | | |
87679-71-8 | | | | | | |
87683-74-7 | | restriction endonuclease acc i from*acinetobactor | | | | |
87684-87-5 | | l-lactic acid-13c3 | | | | |
87686-74-6 | | 8-p-coumaroylharpagide | | | | |